LU91785I2
N-pyrazole a 2a receptor agonists
Abstract
2-Adenosine N-pyrazole compounds having formula (1) and methods for using compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.
Term
4.4 yearsto projected expiry
Projected expiry 31 January 2031, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
62 members in 27 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 33818599 | United States of America | A | |
| 33818599 | United States of America | A | |
| 0040281 | United States of America | W | |
| 0040281 | United States of America | W | |
| US19990338185 | – | – | – |
| WO2000US40281 | – | – | – |
Members62
| Document | Office | Kind | |
|---|---|---|---|
| CA2377746A1 | Canada | A1 | |
| WO0078779A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7132400A | Australia | A | |
| WO0078779A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20016350D0 | Norway | D0 | |
| NO20016350L | Norway | L | |
| EP1189916A2 | European Patent Office (EPO) | A2 | |
| KR20020028910A | Republic of Korea | A | |
| US6403567B1 | United States of America | B1 | |
| MXPA01013325A | Mexico | A | |
| CN1358191A | China | A | |
| IL147198D0 | Israel | D0 | |
| TR200200588T2 | Türkiye | T2 | |
| AR024441A1 | Argentina | A1 | |
| HK1044952A1 | Hong Kong, China | A1 | |
| JP2003506461A | Japan | A | |
| AU760806B2 | Australia | B2 | |
| US6642210B1 | United States of America | B1 | |
| ZA200200301B | South Africa | B | |
| EP1189916B1 | European Patent Office (EPO) | B1 | |
| AT256141T | Austria | T | |
| ATE256141T1 | Austria | T1 | |
| DE60007127D1 | Germany | D1 | |
| BR0011856A | Brazil | A | |
| US2004038928A1 | United States of America | A1 | |
| DK1189916T3 | Denmark | T3 | |
| PT1189916E | Portugal | E | |
| NZ516334A | New Zealand | A | |
| ES2209974T3 | Spain | T3 | |
| DE60007127T2 | Germany | T2 | |
| CN1167709C | China | C | |
| KR100463300B1 | Republic of Korea | B1 | |
| HK1044952B | Hong Kong, China | B | |
| TWI230161B | Taiwan Province of China | B | |
| US2006052332A1 | United States of America | A1 | |
| IL147198A | Israel | A | |
| NO322457B1 | Norway | B1 | |
| US7144872B2 | United States of America | B2 | |
| US7183264B2 | United States of America | B2 | |
| CA2377746C | Canada | C | |
| US2007203090A1 | United States of America | A1 | |
| US7655637B2 | United States of America | B2 | |
| US2010160620A1 | United States of America | A1 | |
| NO2011002I1 | Norway | I1 | |
| FR11C0004I1 | France | I1 | |
| LU91785I2This record | Luxembourg | I2 | |
| DE122011000010I1 | Germany | I1 | |
| US2011144320A1 | United States of America | A1 | |
| JP4727880B2 | Japan | B2 | |
| CY2011002I1 | Cyprus | I1 | |
| CY2011002I2 | Cyprus | I2 | |
| FR11C0004I2 | France | I2 | |
| US8278435B2 | United States of America | B2 | |
| NO2011002I2 | Norway | I2 | |
| US2013058866A1 | United States of America | A1 | |
| US8569260B2 | United States of America | B2 | |
| US2014073596A1 | United States of America | A1 | |
| BR0011856B1 | Brazil | B1 | |
| US9045519B2 | United States of America | B2 | |
| USRE47351E | United States of America | E | |
| BE2011C004I2 | Belgium | I2 | |
| BRPI0011856B8 | Brazil | B8 |
Numbers
- Publication, DOCDB
- 91785
- Publication, EPODOC
- LU91785I
- Application
- 91785
- Application, DOCDB
- 91785
- Application, EPODOC
- LU20110091785C
Titles2
- French
- Rapiscan - régadénoson et ses sels.
- English
- Rapiscan - regadenoson and its salts.
Classification
- CPC, 9
- C07H19/16
- C07D473/34
- A61P29/00
- A61P43/00
- A61P7/00
- A61P7/02
- A61P9/00
- A61P9/08
- A61P9/10
- IPC, 9
- C07H19 167
- A61K31 7076
- A61P7 00
- A61P7 02
- A61P9 00
- A61P9 10
- A61P29 00
- A61P43 00
- C07H19 16